Summary
This randomised controlled trial, published in the Journal of the American College of Cardiology, examined hybrid coronary revascularisation as a treatment approach for multivessel coronary artery disease. Hybrid revascularisation combines minimally invasive direct coronary artery bypass with percutaneous coronary intervention to potentially optimise outcomes. The study assessed safety, efficacy, and clinical outcomes in a multicentre US setting.
UK applicability
Findings are directly applicable to UK cardiology practice, as this represents an advanced intervention approach potentially relevant to NHS cardiac centres. However, implementation would depend on local infrastructure, training capacity, and commissioning decisions within UK cardiac networks.
Key measures
Major adverse cardiac and cerebrovascular events (MACCE), mortality, myocardial infarction, revascularisation rates, and functional outcomes
Outcomes reported
The study evaluated the safety and efficacy of hybrid coronary revascularisation (combining minimally invasive direct coronary artery bypass with percutaneous coronary intervention) compared to conventional approaches for treating multivessel coronary artery disease.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.